Booz VP Advises Pharma: Show Value To Gain Market Access
Pharma's rapidly changing commercial environment has forced companies to re-think their traditional approaches to marketing.
You may also be interested in...
The pharmaceutical industry continues to invest heavily in promotional activities even as many drugs go off patent and new drug launches become less frequent.
The 25th annual Ernst & Young report shows that biotechs have fewer exit strategies than ever and that pre-clinical stage companies still have a hard time finding financing.
Medicare-sanctioned accountable care organizations could significantly improve drug adherence among beneficiaries as a way to prevent more costly medical interventions later, under a widely-anticipated CMS proposal.